Barclays reaffirmed their overweight rating on shares of NMC Health (LON:NMC) in a report issued on Tuesday.

A number of other equities analysts have also recently commented on NMC. Berenberg Bank reiterated a buy rating and set a GBX 4,600 ($60.11) price target on shares of NMC Health in a report on Monday, June 11th. JPMorgan Chase & Co. reiterated a neutral rating and set a GBX 4,060 ($53.05) price target (up previously from GBX 3,270 ($42.73)) on shares of NMC Health in a report on Tuesday, August 21st.

NMC Health stock opened at GBX 3,134 ($40.95) on Tuesday. NMC Health has a 52 week low of GBX 1,726 ($22.55) and a 52 week high of GBX 3,558 ($46.49).

About NMC Health

NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The company operates through two businesses, NMC Healthcare and NMC Trading. It owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers.

See Also: Conference Calls

Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.